ESPR
Esperion Therapeutics Inc
3.20$
+0.0%
vs. previous close
Closing price · As of: Jul 15, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -96.0% | -56.9% | -114.9% | 39.1% | -9.8% | -68.4% | -50.6% | -34.8% | -38.1% | -4.9% | 26.9% | -34.6% | -4.3% | |
| 0.2% | 0.1% | 0.0% | 0.3% | 0.0% | -0.8% | 0.0% | 1.1% | 0.0% | 0.0% | 0.8% | 0.0% | 0.4% | |
| 12.3% | 8.8% | 9.1% | 2.3% | 4.0% | 5.9% | 4.1% | 3.8% | 3.2% | 2.7% | 1.4% | 3.1% | 2.4% | |
| 12.3% | 43.8% | – | – | – | – | – | – | – | – | – | – | – | |
| 39.4% | 19.4% | 12.3% | -15.8% | -6.8% | -24.1% | -30.8% | 18.5% | -31.9% | 24.0% | -12.7% | -1.3% | -6.6% | |
| 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.2% | 0.1% | |
| 67.9% | – | – | -0.1% | -0.1% | -0.3% | – | – | – | – | 0.1% | -0.2% | – | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | |
| -186.6% | -0.1% | 0.1% | – | -465.6% | 665.8% | – | – | – | – | – | – | – | |
| 3.1% | -12.7% | 13.9% | 65.8% | -40.7% | -17.6% | 50.6% | -11.5% | 3.5% | 12.2% | 17.9% | 20.2% | 14.3% | |
| -25.0% | -69.6% | -101.0% | 104.8% | -50.5% | -86.4% | 0.1% | -46.4% | -34.7% | 7.3% | 44.8% | -14.6% | 9.9% | |
| -96.0% | -56.9% | -114.9% | 39.0% | -9.9% | -68.7% | -50.6% | -34.8% | -38.1% | -4.9% | 27.0% | -34.8% | -4.3% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 15, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.